The medical affairs function continues to evolve and adapt to a collaborative role with companies’ research and commercial functions

At the same time, it must remain vigilant in its compliance with regulatory guidelines and ethics. To succeed in this environment, many biopharmaceutical companies need to undertake transformational initiatives to better engage a breadth of stakeholders with timely and relevant value-added products and services.

AstaLynx provides a wide range of Medical Affairs Expertise that enables clients to meet their requirements for scientific publication, medical marketing material and regulatory submission across diversified therapeutic areas. We are dedicated to delivering the highest quality documents for both stand-alone basis as well as for an integrated section of a clinical study.

Our highly skilled and professional Medical Affairs team works with our operational departments that include late phase studies, early phase interventional trials, data management, pharmacovigilance, and regulatory affairs to provide meticulous and efficient documents to the top-notch standards.

Our regulatory affairs team comprises of experts in the preparation, compilation, and delivery of regulatory submissions.

Our responsive and customer-centric approach enables our clients to have instant communication during each stage of the project.

Our medical affairs service portfolio